Search Results

Business

Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development

Intravacc and Primrose Bio announced a strategic partnership to enhance the development and supply of conjugate vaccines.

March 28, 2024

·

3 min read

Drug Development

Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2

Intravacc, a world leader in translational research and development of preventive and therapeutic vaccines, announced positive clinical data of a first in human study of Avacc 10®, an intranasal outer membrane vesicles based booster vaccine for SARS-CoV-2.

March 26, 2024

·

3 min read

Intravacc launches new website with a wealth of scientific knowledge to elevate vaccine innovation

Intravacc, a globally recognized pioneer and leader in translational vaccinology, announced the launch of its new website.

December 20, 2023

·

3 min read

Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections

Intravacc announced that it has been awarded a funding that may total US$ 633K from CARB-X a global non-profit organisation, for the development of a preventive vaccine against Neisseria gonorrhoeae.

January 16, 2024

·

4 min read

Intravacc announces publication of In Vitro alternative to replace animal pyrogen test for vaccines

Intravacc announced the publication of a scientific article of an in vitro alternative assay to the replace rabbit pyrogen test for vaccines.

September 19, 2023

·

5 min read

Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention

Intravacc, a leading Contract Development and Manufacturing Organization specializing in translational research and the development of preventive and therapeutic vaccines, has announced the publication of a review on the efficacy of intranasally administered outer membrane vesicle -based vaccines.

September 14, 2023

·

3 min read

EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine

EpiVax, Inc. (“EpiVax”) is pleased to announce participation in a new project with Intravacc, funded by CEPI (Coalition for Epidemic Preparedness Innovations), to develop universal vaccines for betacoronaviruses, including SARS-CoV-2.

October 31, 2022

·

2 min read

Leiden University Medical Center and Intravacc to Start Clinical Trial with New Intranasal Corona Vaccine

Intravacc, a global leader in translational research and development of therapeutic vaccines and vaccines against infectious diseases, announced a partnership with Dutch Leiden University Medical Center to develop and evaluate a new nasal spray corona vaccine in a clinical phase I/II study.

January 5, 2022

·

4 min read

Intravacc and EpiVax Team up in Development of COVID-19 Emerging Vaccine

Intravacc, one of the world’s leading translational research and development vaccine institutes, with an extensive track record in developing viral and bacterial vaccines, and EpiVax, a biotechnology company based in Providence with expertise in developing vaccines and therapeutics

June 2, 2020

·

4 min read

Intravacc Partners With Wageningen Bioveterinary Research and Utrecht University to Develop an Intranasal COVID-19 Vaccine

Intravacc, one of the world’s leading translational research and development vaccine institutes, with an extensive track record in developing viral and bacterial vaccines, has announced more details on its development of an intranasal vaccine against COVID-19.

June 4, 2020

·

4 min read